Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.20.4
CONSOLIDATED STATEMENTS OF CASH FLOWS
$ in Thousands
12 Months Ended
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Cash flows from operating activities:      
Net (loss) income $ (281,704) $ 80,310 $ 59,621
Net (loss) income from discontinued operations, net of tax 102,241 (14,557) (9,242)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:      
Depreciation 114,641 111,032 111,491
Amortization 37,199 40,765 42,440
Goodwill impairment charge 260,000 0 0
Amortization of deferred financing costs and original issue discount 3,750 3,786 4,230
Debt extinguishment costs 22,658 3,400 5,627
Foreign currency exchange (gain) loss (4,172) 2,410 12,543
Pension and postretirement healthcare benefit expense 879 3,536 2,280
Pension and postretirement healthcare benefit funding (9,138) (8,825) (6,805)
Deferred income tax provision (benefit) (64,693) 15,489 4,072
Net (gain) loss on asset disposals (11,392) (13,207) 4,190
Stock compensation 21,527 16,212 18,419
Equity in net income from affiliated companies (21,237) (46,022) (37,569)
Dividends received from affiliated companies 40,098 40,073 40,195
Net interest income on swaps designated as net investment hedges (4,963) (8,480) (4,859)
Gain on contract termination 0 0 (20,612)
Other, net (9,479) (5,292) (907)
Working capital changes that provided (used) cash, excluding the effect of acquisitions and dispositions:      
Receivables 7,031 11,407 (4,191)
Inventories 9,392 (9,981) (7,165)
Prepaids and other current assets 2,016 2,294 (6,996)
Accounts payable 4,163 (576) (3,491)
Accrued liabilities (13,435) 3,886 9,855
Net cash provided by operating activities, continuing operations 205,382 227,660 213,126
Net cash provided by operating activities, discontinued operations 18,216 40,103 35,518
Net cash provided by operating activities 223,598 267,763 248,644
Cash flows from investing activities:      
Purchases of property, plant and equipment (97,135) (111,102) (111,795)
Investment in affiliated companies 0 0 (5,000)
Net proceeds received from the sale of Performance Materials 624,256 0 0
Proceeds from sale of assets 9,375 17,600 12,380
Proceeds from sale of product line 18,000 27,658 0
Proceeds from sale of investment 1,761 0 0
Proceeds from settlement of swaps designated as net investment hedges 0 38,070 0
Net interest proceeds on swaps designated as net investment hedges 4,963 8,480 4,859
Other, net 1,015 475 829
Net cash provided by (used in) investing activities, continuing operations 562,235 (18,819) (98,727)
Net cash (used in) provided by investing activities, discontinued operations (10,763) (16,540) (20,563)
Net cash (used in) provided by investing activities 551,472 (35,359) (119,290)
Cash flows from financing activities:      
Draw down of revolving credit facilities 140,626 177,874 119,134
Repayments of revolving credit facilities (140,626) (177,874) (144,134)
Issuance of long-term debt, net of original issue discount and financing fees 640,340 0 1,267,000
Debt issuance costs (8,987) 0 (6,395)
Repayments of long-term debt (1,091,134) (215,000) (1,367,959)
Debt prepayment fees (10,550) 0 0
Dividends paid to stockholders 243,749 0 0
Repurchases of common shares (4,598) (3,563) (2,920)
Proceeds from stock options exercised 373 3,975 131
Other, net (2,868) (317) (134)
Net cash used in financing activities, continuing operations (721,173) (214,905) (135,277)
Net cash used in financing activities, discontinued operations (1,647) (1,188) (1,948)
Net cash used in financing activities (722,820) (216,093) (137,225)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 11,052 (2,120) 354
Net change in cash, cash equivalents and restricted cash 63,302 14,191 (7,517)
Cash, cash equivalents and restricted cash at beginning of period 73,917 59,726 67,243
Cash, cash equivalents and restricted cash at end of period 137,219 73,917 59,726
Less cash, cash equivalents and restricted cash of discontinued operations 0 (18,725) (21,127)
Cash, cash equivalents and restricted cash at end of period of continuing operations $ 137,219 $ 55,192 $ 38,599